Carregant...
Blocking autophagy enhances meloxicam lethality to hepatocellular carcinoma by promotion of endoplasmic reticulum stress
OBJECTIVES: Meloxicam, a selective cyclooxygenase‐2 (COX‐2) inhibitor, has been demonstrated to exert anti‐tumour effects against various malignancies. However, up to now, mechanisms involved in meloxicam anti‐hepatocellular carcinoma effects have remained unclear. MATERIALS AND METHODS: Cell viabil...
Guardat en:
| Publicat a: | Cell Prolif |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6496225/ https://ncbi.nlm.nih.gov/pubmed/26481188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12221 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|